Sistema reports arrest of its stakes in MTS, Medsi, BES as part of dispute with RosneftBusiness & Economy June 26, 20:58
Russian submarine successfully test-fires Bulava intercontinental missileMilitary & Defense June 26, 19:20
Rosneft and RBC reach friendly settlement on defamation lawsuitBusiness & Economy June 26, 18:50
Number of centers issuing FAN IDs to be increased ahead of FIFA Confederations Cup FinalSport June 26, 18:33
News about anti-doping probe against Russian football team players is fake — executiveSport June 26, 18:25
Putin refers to State Duma Council of Europe convention against financing terrorismRussian Politics & Diplomacy June 26, 18:15
Russia to lay down 2 diesel-electric submarines for Pacific Fleet in JulyMilitary & Defense June 26, 18:07
Russia’s Khramtsov wins first gold at 2017 World Taekwondo ChampionshipsSport June 26, 18:03
Russian Navy to get four frigates by 2020Military & Defense June 26, 17:41
MOSCOW, October 10 (Itar-Tass) — Russia’s ex-finance minister Alexei Kudrin insists that the country should invest more money into healthcare and less into defence.
“Russia still has to go down the path of increasing expenditures on healthcare. In this respect I would inject less into military needs than into healthcare,” he told the forum dealing with the Sixth Millennium Development Goal MDG-6 that opened in Moscow on Monday.
He reiterated his position saying that “an increase in military spending poses a threat to the support and development of healthcare and education programs.” “This is the reason of my conflict with the Russian incumbent president.”
In late September Alexei Kudrin resigned after a disagreement with President Dmitry Medvedev’s economic policy targeted at increasing expenditures on defence.
Speaking about reaching the development goals, mainly the goal to combat HIV/AIDS, malaria and other diseases, Kudrin stressed the need for creating a mechanism that would attract large pharmaceutical corporations to work in less developed countries and for the poor, as well-to-do people have access to most state-of-the-art medicines.